|
SocialPicks Sentiment:
N/A
** not enough data to be rated
|
This Quarter's Sentiment:
|
|
|
ARYX Analysis & Videos »
ARYX: Bull or Bear?
ARYx THERAPEUTICS: 143 SHAREHOLDER VICTIMIZED IN ONE DAY
ARYX
|
|
|
+72.86%
in
208 days
(closed on 09/17/10)
This is the same situation like XNPT so the text is the same, the only difference that in ARYX case insiders were not selling before stock tanked. Today it's down 50% and same institutions here hold 40% of the company shares, insiders 15% and the rest private investors.
I will not go inside balance sheet details it makes no sense, the price is the final judge. Another biotech just one day later proves how "smart" investors now s... about how to value all biotechs.
The only good thing here is that ARYX never was worth 2,000,000,000$ like XNPT but it didn't prevented MPM Asset Managemen...
|
Extreme FDA Calendar Trades: 18 Stocks Under $5
ARYX
|
|
|
-47.12%
in
6 days
(closed on 07/09/09)
<> Below are extreme trades among companies with stock prices under $5 from the <font> BioMedReports.com FDA Calendar </font> , which includes 232 entries as of 7/3/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissio...
|
FDA Calendar Updates: BDSI is Worth the Wait, Zicam Warning
ARYX
|
|
|
-1.53%
in
17 days
(closed on 07/03/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-st...
|
People Bullish on ARYX
People Bearish on ARYX
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on ARYX |
More Resources
|
About ARYx Therapeutics Inc.
- Answers.com
